Level of adherence to the GOLD strategy document for management of patients admitted to hospital with an acute exacerbation of COPD

Respirology

Volumn 19, Issue 8, 2014, Pages 1191-1197

  Tang, Clarice Y ^a,b   Taylor, Nicholas F ^a   McDonald, Christine F ^c,d   Blackstock, Felicity C ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b WESTERN HEALTH   (Australia)

^c AUSTIN HEALTH   (Australia)

^d INSTITUTE FOR BREATHING AND SLEEP   (Australia)

Author keywords

Acute disease; Chronic obstructive; Guideline adherence; Inpatient; Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; ANTIINFECTIVE AGENT;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENERAL PRACTICE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH CARE MANAGEMENT; HEALTH PRACTITIONER; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OXYGEN THERAPY; PATIENT REFERRAL; PRESCRIPTION; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; AUSTRALIA; CLINICAL AUDIT; HEALTH SERVICE; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PROCEDURES; PROTOCOL COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA;

AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; BRONCHODILATOR AGENTS; CLINICAL AUDIT; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALIZATION; HUMANS; MIDDLE AGED; OXYGEN INHALATION THERAPY; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SMOKING CESSATION;

EID: 84908016979     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12361     Document Type: Article

References (34)

1. Australian Centre for Asthma Monitoring. Asthma in Australia 2011: With a Focus Chapter on Chronic Obstructive Pulmonary Disease. AIHW, Canberra, 2011. Asthma series no. 4. Cat. no. ACM 22. [Accessed 21 Jun 2014.] Available from URL: http://www.aihw.gov.au/publication-detail/?id=10737420159/
2. McKenzie DK, Abramson M, Crockett AJ, Dabscheck E, Glasgow N, Jenkins S, McDonald CF, Wood-Baker R, Yang I, Frith PA et al. The COPD-X plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease V2.30, 2011. 2011. [Accessed 1 May 2013.] Available from URL: http://www.copdx.org.au/
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-76.
4. Rodriguez-Roisin R, Anzueto A, Bourbeau J, deGuia T, Hui D, Martinez F, Mishima M, Nugmanova D, Ramirez A, Stockley R et al. Global strategy for the diagnosis, management and the prevention of chronic obstructive pulmonary disease (updated 2011). 2011. [Accessed 1 May 2013.] Available from URL: http://www.goldcopd.org/uploads/users/files/GOLDReport-April112011.pdf
5. Decramer M, Vestbo J, Bourbeau J, Celi B, Hui D, Varela MV, Nishimura M, Roisin R, Stockley R, Vogelmeier C. Global initiative for chronic obstructive lung disease- pocket guide to COPD diagnosis, management and prevention (updated 2013). 2013. [Accessed 1 May 2013.] Available from URL: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management
6. Asche CV, Leader S, Plauschinat C, Raparia S, Yan M, Ye X, Young D. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 7: 201-9.
7. Australian Institute of Health and Welfare. Australian Hospital 2010-2011 at a glance. 2011. [Accessed 1 May 2013.] Available from URL: http://www.aihw.gov.au/publication-detail/?id=10737418683
8. Urbaniak G, Plous S. Research randomizer. 1997. [Accessed 1 Nov 2013.] Available from URL: http://www.randomizer.org/
9. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2006; (4): CD003793.
10. Puhan M, Gimeno-Santos E, Scharplatz M, Troosters T, Walters E, Steurer J. Pulmonary rehabilitation following exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2009; (9): CD005305.
11. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390-413.
12. Scanlon P, Connett J, Waller L, Altose M, Bailey W, Buist A. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161: 381-90.
13. Wongsurakiat P, Manranetra K, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 2011-20.
14. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 2009; 58: 1-52.
15. Fritsch K, Jacot M, Klarer A, Wick F, Bruggmann P, Krause M, Thurnbeer R. Adherence to the Swiss guidelines for management of COPD experience of a Swiss teaching hospital. Swiss Med. Wkly 2005; 135: 116-21.
16. Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, Leuppi JD. General practitioner's adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD cohort study. Swiss Med. Wkly 2010; 140: 1-8.
17. Jochmann A, Scherr A, Jochmann D, Miedinger D, Török SS, Chhajed PN, Tamm M, Leuppi JD. Impact of adherence to the GOLD guidelines on symptom, prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med. Wkly 2012; 142: 1-11.
18. Ta M, George J. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines. Intern. Med. J. 2011; 41: 263-9.
19. Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir. Med. 2012; 106: 374-81.
20. Wihayaratne K, Wilson J, Sivakumaran P, Sriram KB. Differences in care between general medicine and respiratory specialists in management of patients hospitalised for acute exacerbations of chronic obstructive pulmonary disease. Ann. Thorac. Med. 2013; 8: 197-203.
21. Pretto J, McDonald V, Wark P, Hensley M. Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines. Intern. Med. J. 2012; 42: 380-7.
22. Hambleton S. Public Hospital Report Card 2011: An AMA Analysis of Australia's Public Hospital System. AMA, Canberra, 2011.
23. Durkin S, Brennan E, Wakefield M. Mass media campaigns to promote smoking cessation among adults: an integrative review. Tob. Control 2012; 21: 127-38.
24. Teasell R, Foley N, Salter K, Jutai J. A blueprint for transforming stroke rehabilitation care in Canada: the case for change. Arch. Phys. Med. Rehabil. 2008; 89: 575-8.
25. Feifer C, Ornstein S. Strategies for increasing adherence to clinical guidelines and improving patient outcomes in small primary care practices. Jt Comm. J. Qual. Patient Saf. 2004; 30: 432-41.
26. Grol R, Grimshaw J. Frombest evidence to best practice: effective implementation of change in patient's care. Lancet 2003; 362: 1225-30.
27. Campbell S, MacDonald M, Carr B, Anderson D, MacKinley R, Cairns S. Bridging the gap between primary and secondary care: use of a clinical pathway for the investigation and management of deep vein thrombosis. J. Health Serv. Res. Policy 2007; 13: 15-19.
28. O'Donnell D, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can. Respir. J. 2007; 14(Suppl. B): 5B-32B.
29. Celi B, MacNee W, Anzueto A, Berg B, Buist A, Calverley P, Chavannes N, Dillard T, Fahy B, Fein A et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2014; 23: 932-46.
30. Ram F, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes N. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2006; (19): CD004403.
31. Ong S, Nakase J, Moran G, Karras D, Kuehnert M, Talan D. Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations and patient satisfaction. Ann. Emerg. Med. 2007; 50: 213-20.
32. Leuppi J, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S et al. Short-termvs conventional glucorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309: 2223-31.
33. Walters J, Wang W, Morley C, Solatni A, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; (10): CD006897. doi:10.1002/1465185.CD006897.pub2.
34. Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S; European COPD Audit team. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax 2013; 68: 1169-71.